Jeffrey Scott Loveall, PA

Jeffrey Loveall practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Jeffrey Loveall's NPI, 1013927409, was assigned on August 8, 2006. Jeffrey Loveall holds California license PA17130.

Jeffrey Loveall's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Jeffrey Loveall's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Jeffrey Loveall to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeffrey Loveall practices. Vendor and product names are available with a free account.

Physician assistant is Jeffrey Loveall's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Jeffrey Loveall is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Jeffrey Loveall is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, chest wall injury, conjunctivitis, contact dermatitis, ear eustachian tube disorders, ear infection and fluid and electrolyte imbalances among the conditions Jeffrey Loveall treats.

CMS data shows 248 Medicare services from Jeffrey Loveall across 5 procedure codes in 2024, for 191 Medicare patients. Medicare paid $15,866 for them. Every service was in an office.

CMS counts 191 Medicare patients who saw Jeffrey Loveall in 2024. The largest group is 65 to 74, with 95 patients. 65% of them have high blood pressure, and 58% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jeffrey Loveall's median patient age at 53, with 57% women.

In 2024, Jeffrey Loveall wrote 294 Medicare Part D claims for 213 patients. 92% of them were for generic drugs. CMS names the drug for 169 of them, across 6 drugs with 11 or more claims each, at $1,685 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Jeffrey Loveall for performance year 2024, reported as part of a group. Jeffrey Loveall accepts Medicare assignment, so Medicare's approved amount is taken as full payment.